-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Nexien Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2024.
- Nexien Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$39.5K, a 61% decline year-over-year.
- Nexien Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$211K, a 22.6% increase year-over-year.
- Nexien Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$239K, a 33.9% increase from 2023.
- Nexien Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$362K, a 42.2% increase from 2022.
- Nexien Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$626K, a 66.3% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)